(Q44963911)

English

RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer

scientific article published on 7 March 2011

Statements

RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer (English)
Nicholas J Robert
Véronique Diéras
John Glaspy
Adam M Brufsky
Oleg N Lipatov
Stephen Y T Chan
Xian Zhou
See-Chun Phan
7 March 2011
1252-1260

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit